These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 14523056

  • 1. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model.
    Sadahiro S, Suzuki T, Ishikawa K, Tanaka Y, Masuda T, Nakamura T, Yasuda S, Makuuchi H, Murayama C.
    Jpn J Clin Oncol; 2003 Aug; 33(8):377-81. PubMed ID: 14523056
    [Abstract] [Full Text] [Related]

  • 2. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C, Levi F, Kreutz F, Focan-Henrard D, Lobelle JP, Adam R, Dallemagne B, Jehaes C, Markiewicz S, Weerts J, Bismuth H, Jasmin C, Misset JL.
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [Abstract] [Full Text] [Related]

  • 3. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M, Müller HH.
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [Abstract] [Full Text] [Related]

  • 4. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
    Meta-Analysis Group in Cancer, Piedbois P, Buyse M, Kemeny N, Rougier P, Carlson R, Allen-Mersh T, O'Connell M, Chang A, Sondak V, Kemeny M, Levy E.
    J Natl Cancer Inst; 1996 Mar 06; 88(5):252-8. PubMed ID: 8614003
    [Abstract] [Full Text] [Related]

  • 5. Intrahepatic arterial infusion of chemotherapy: pharmacologic principles.
    Ensminger WD.
    Semin Oncol; 2002 Apr 06; 29(2):119-25. PubMed ID: 11951209
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
    Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV.
    J Clin Oncol; 1997 Apr 06; 15(4):1432-8. PubMed ID: 9193336
    [Abstract] [Full Text] [Related]

  • 7. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.
    Gan To Kagaku Ryoho; 1999 Feb 06; 26(3):269-81. PubMed ID: 10065089
    [Abstract] [Full Text] [Related]

  • 8. [The evaluation of weekly hepatic arterial infusion of high-dose 5-FU for liver metastases from colorectal cancer].
    Hata Y, Morita S, Noda Y, Kawasaki R, Morita Y, Awatani T, Horimi T.
    Gan To Kagaku Ryoho; 1998 May 06; 25(6):901-5. PubMed ID: 9617329
    [Abstract] [Full Text] [Related]

  • 9. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
    Hoshino S, Yamashita Y, Maekawa T, Shirakusa T.
    Cancer Chemother Pharmacol; 2005 Dec 06; 56(6):648-52. PubMed ID: 15959779
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of intermittent hepatic arterial infusion chemotherapy for multiple liver metastasis of colorectal cancer].
    Yoshioka S, Morimoto T, Shingai T, Azama T, Katsumoto Y, Nakaguchi K, Furukawa J, Okajima S, Sue F.
    Gan To Kagaku Ryoho; 1999 Oct 06; 26(12):1721-4. PubMed ID: 10560380
    [Abstract] [Full Text] [Related]

  • 11. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.
    Copur MS, Capadano M, Lynch J, Goertzen T, McCowan T, Brand R, Tempero M.
    J Clin Oncol; 2001 May 01; 19(9):2404-12. PubMed ID: 11331319
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
    Kosaka K, Nishino H, Yamada N, Nishihara T, Ohira M, Hirakawa K.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(11):1647-50. PubMed ID: 14619485
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
    Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Hohenberger P, Irngartinger G, Oberdorfer F, Doll J, van Kaick G.
    J Nucl Med; 1998 Mar 01; 39(3):465-73. PubMed ID: 9529293
    [Abstract] [Full Text] [Related]

  • 19. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE.
    J Clin Oncol; 1998 Jul 01; 16(7):2528-33. PubMed ID: 9667274
    [Abstract] [Full Text] [Related]

  • 20. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
    Benson AB.
    Oncology (Williston Park); 1998 Oct 01; 12(10 Suppl 7):28-34. PubMed ID: 9830622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.